Feb 10 (Reuters) - Radiopharm Theranostics RAD.AX:
NEW CLINICAL TRIAL DATA HIGHLIGHTS RAD 101 (18F-PIVALATE) SUCCESSFULLY DETECTS BRAIN METASTASES
Source text: ID:nGNX2bNwLD
Further company coverage: RAD.AX
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.